Biomarkers in stable coronary artery disease.


Journal Article (Review)

Coronary artery disease (CAD) remains a significant cause of morbidity and mortality around the world. Patients with stable CAD can have an unpredictable clinical trajectory; thus, additional tools to prognosticate risk in this cohort are warranted. In recent years, a wide range of biomarkers has been recognized for their diagnostic capabilities in patients with stable CAD, identifying those with obstructive disease who may require more intensive preventive therapies or even consideration of percutaneous coronary intervention in some circumstances. In addition, a multiple-biomarker approach may identify stable CAD patients at highest risk for future major adverse cardiac events. Thus, randomized controlled trials to assess biomarker-guided preventive therapy in this cohort appear warranted.

Full Text

Duke Authors

Cited Authors

  • McCarthy, CP; McEvoy, JW; Januzzi, JL

Published Date

  • February 2018

Published In

Volume / Issue

  • 196 /

Start / End Page

  • 82 - 96

PubMed ID

  • 29421018

Pubmed Central ID

  • 29421018

Electronic International Standard Serial Number (EISSN)

  • 1097-6744

Digital Object Identifier (DOI)

  • 10.1016/j.ahj.2017.10.016


  • eng

Conference Location

  • United States